questionText: To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the availability of givinostat to patients eligible through early access programmes.
answerText: The Department understands the impact that Duchenne muscular dystrophy has on those living with it, and their families, and the urgent need for new treatment options. If new therapies for Duchenne muscular dystrophy are approved by the National Institute ...
heading: Givinostat